NO20043000L - A preparation for the treatment of neurocerebrovascular diseases - Google Patents
A preparation for the treatment of neurocerebrovascular diseasesInfo
- Publication number
- NO20043000L NO20043000L NO20043000A NO20043000A NO20043000L NO 20043000 L NO20043000 L NO 20043000L NO 20043000 A NO20043000 A NO 20043000A NO 20043000 A NO20043000 A NO 20043000A NO 20043000 L NO20043000 L NO 20043000L
- Authority
- NO
- Norway
- Prior art keywords
- neurocerebrovascular
- diseases
- preparation
- treatment
- neurocerebrovascular diseases
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/121—Ketones acyclic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Botany (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Hematology (AREA)
- Biotechnology (AREA)
- Heart & Thoracic Surgery (AREA)
- Neurology (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Physical Education & Sports Medicine (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Toxicology (AREA)
- Biochemistry (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US34016501P | 2001-12-14 | 2001-12-14 | |
PCT/IB2002/005366 WO2003051380A2 (en) | 2001-12-14 | 2002-12-14 | Compositions containeing curcuma extracts for the treatment of neurocerebrovascular disorders |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20043000L true NO20043000L (en) | 2004-07-13 |
NO332066B1 NO332066B1 (en) | 2012-06-18 |
Family
ID=23332163
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20043000A NO332066B1 (en) | 2001-12-14 | 2004-07-13 | A composition useful for the treatment of neurocerebrovascular diseases, and the use of said composition for the manufacture of a medicament for the treatment of neurocerebrovascular diseases. |
Country Status (19)
Country | Link |
---|---|
US (2) | US20060051438A1 (en) |
EP (1) | EP1453528B1 (en) |
JP (1) | JP4695839B2 (en) |
KR (1) | KR101001815B1 (en) |
CN (1) | CN100528149C (en) |
AU (2) | AU2002348802A1 (en) |
BR (1) | BR0214962A (en) |
CA (1) | CA2473874C (en) |
DE (1) | DE60233069D1 (en) |
EA (1) | EA007067B1 (en) |
EE (1) | EE05374B1 (en) |
GE (1) | GEP20084442B (en) |
LT (1) | LT5284B (en) |
LV (1) | LV13250B (en) |
MX (1) | MXPA04005680A (en) |
NO (1) | NO332066B1 (en) |
UA (1) | UA82057C2 (en) |
WO (1) | WO2003051380A2 (en) |
ZA (1) | ZA200404648B (en) |
Families Citing this family (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1956713A (en) * | 2004-05-31 | 2007-05-02 | 株式会社钟化 | Agent for preventing/amelioration life style-related diseases containing turmeric essential oil component |
WO2006118079A1 (en) * | 2005-04-28 | 2006-11-09 | Arata Yamasaki | Antiaging agnet for skin |
US9492402B2 (en) | 2005-05-30 | 2016-11-15 | Benny Antony | Formulation of curcuminoids with enhanced bioavailability of curcumin, demethoxycurcumin, bisdemethoxycurcumin and method of preparation and uses thereof |
US10543277B2 (en) | 2005-05-30 | 2020-01-28 | Arjuna Natural Private Limited | Formulation of curcumin with enhanced bioavailability of curcumin and method of preparation and treatment thereof |
HUE042590T2 (en) * | 2005-05-30 | 2019-07-29 | Benny Antony | Method for improving the bioavailability of curcumin |
US8859020B2 (en) | 2005-05-30 | 2014-10-14 | Benny Antony | Treatment of alzheimer's with a curcuminoid mixture and essential oil of turmeric having 45% Ar-turmerone |
US10286027B2 (en) | 2005-05-30 | 2019-05-14 | Arjuna Natural Extracts, Ltd. | Sustained release formulations of curcuminoids and method of preparation thereof |
US7883728B2 (en) | 2005-05-30 | 2011-02-08 | Arjuna Natural Extracts, Ltd. | Composition to enhance the bioavailability of curcumin |
JP4980626B2 (en) * | 2006-02-28 | 2012-07-18 | ポーラ化成工業株式会社 | Plasminogen activator inhibitor I inhibitor and food composition comprising the same |
JP5207341B2 (en) * | 2006-10-26 | 2013-06-12 | 独立行政法人産業技術総合研究所 | Inflammatory cytokine production inhibitor |
WO2009043176A1 (en) | 2007-10-03 | 2009-04-09 | Sabell Corporation | Herbal compositions and methods for treating hepatic disorders |
EP2403334A2 (en) * | 2009-03-05 | 2012-01-11 | Keygene N.V. | Plant volatiles based on r-curcumene |
EP2458983B1 (en) | 2009-07-31 | 2015-07-08 | Cognition Therapeutics, Inc. | Inhibitors of cognitive decline |
JP5764288B2 (en) | 2009-09-24 | 2015-08-19 | ハウス食品グループ本社株式会社 | A composition containing a turmeric extract and a gadget extract |
JP5578822B2 (en) * | 2009-09-25 | 2014-08-27 | 株式会社ピカソ美化学研究所 | Acetylcholinesterase inhibitor |
JP2014511373A (en) | 2011-02-02 | 2014-05-15 | コグニション セラピューティクス インク. | Compounds isolated from turmeric oil and methods of use thereof |
EP2690969B1 (en) * | 2011-03-29 | 2018-10-03 | Council of Scientific & Industrial Research | Process for the modification of curcuma aromatica essential oil |
GB201111319D0 (en) | 2011-07-04 | 2011-08-17 | Univ Leuven Kath | Anticonvulsant activity of tumeric oil and bisabolene sesquiterpenoids of curcuma longa |
KR101832283B1 (en) * | 2012-01-13 | 2018-02-26 | 주식회사 엘지생활건강 | Composition for improving skin wrinkle and enhancing elasticity |
CN102697757B (en) * | 2012-05-18 | 2014-06-04 | ***广州总医院 | Application of p-hydroxy benzylidene acetone in preparation of drugs for preventing and/or treating encephalopathy |
JP2014201528A (en) * | 2013-04-02 | 2014-10-27 | クラシエ製薬株式会社 | Antioxidant |
EP4023294A1 (en) | 2014-01-31 | 2022-07-06 | Cognition Therapeutics, Inc. | Isoindoline compositions and methods for treating alzheimer's disease |
CN106822071B (en) * | 2014-09-23 | 2019-12-27 | 桂林八加一药业股份有限公司 | Chinese medicinal effective component for treating coronary heart disease and hyperlipidemia, its preparation method and method for separating effective component from the same |
CN105738546B (en) * | 2014-12-12 | 2020-01-21 | 桂林八加一药业股份有限公司 | Method for establishing fingerprint of radix curcumae medicinal material and fingerprint thereof |
CN105055449B (en) * | 2015-07-27 | 2019-08-09 | 中国科学院西北高原生物研究所 | A kind of Sailongbone extracts with anti-inflammatory and antalgic activity, preparation method and Chinese materia medica preparation |
CN106492137A (en) * | 2016-12-29 | 2017-03-15 | 王明金 | A kind of treat Chinese medicine composition of depression and preparation method thereof |
CN106491996A (en) * | 2016-12-29 | 2017-03-15 | 王明金 | A kind of treat Chinese medicine composition of manic disorder and preparation method thereof |
CN106511784A (en) * | 2016-12-29 | 2017-03-22 | 王明金 | Traditional Chinese medicine composition for treating mental diseases and preparation method thereof |
CN106491997A (en) * | 2016-12-29 | 2017-03-15 | 王明金 | A kind of Chinese medicine composition of anti-mental disorder and preparation method thereof |
CN110621309A (en) * | 2017-05-12 | 2019-12-27 | 好侍健康食品株式会社 | Anti-inflammatory composition |
BR112019023851A2 (en) | 2017-05-15 | 2020-08-18 | Cognition Therapeutics, Inc. | compounds, their pharmaceutical compositions and methods for treating neurodegenerative diseases |
US10391138B2 (en) * | 2017-07-11 | 2019-08-27 | Muniyal Ayurvedic Research Centre | Multidimensional approach for Cancer treatment |
CN108498755B (en) | 2018-04-17 | 2021-04-09 | 贾洪章 | Chinese medicinal composition for treating cardiovascular and cerebrovascular diseases, and its preparation method and application |
CN112351790A (en) * | 2018-06-29 | 2021-02-09 | 好侍健康食品株式会社 | Composition for treating, preventing or ameliorating alzheimer's disease, composition for inhibiting brain nerve cell death, composition for inhibiting beta amyloid-induced microglial activation, and composition for inhibiting beta amyloid-induced PGE2, TNF- α or IL-1 β production |
CN111617059B (en) * | 2020-05-29 | 2023-07-25 | 广东工业大学 | Application of curcuma zedoary diketone |
CN111617060A (en) * | 2020-05-29 | 2020-09-04 | 广东工业大学 | Application of germacrone |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
LU83350A1 (en) | 1981-05-08 | 1983-03-24 | Oreal | COMPOSITION FOR THE TREATMENT OF KERATINIC FIBERS BASED ON CATIONIC POLYMER AND ANIONIC POLYMER HAVING VINYLSULFONIC GROUPS AND METHOD OF TREATING THE SAME |
IN162441B (en) | 1984-12-26 | 1988-05-28 | Council Scient Ind Res | |
US4842859A (en) * | 1986-09-08 | 1989-06-27 | Yaguang Liu | Pharmaceutical compositions for reducing hyperlipidemia and platelet-aggregation |
US5120538A (en) * | 1990-02-05 | 1992-06-09 | Pt Darya-Varia Laboratoria | Combinations of compounds isolated from curcuma spp as anti-inflammatory agents |
US5863938A (en) * | 1991-03-01 | 1999-01-26 | Warner Lambert Company | Antibacterial-wound healing compositions and methods for preparing and using same |
CN1100321A (en) * | 1994-03-27 | 1995-03-22 | 叶启智 | Zibeth and its compound medical injection |
AU2300001A (en) * | 1999-10-22 | 2001-05-08 | Board Of Trustees Of The University Of Illinois, The | Pharmaceutical compositions useful in the prevention and treatment of beta-amyloid protein-induced disease |
DE10029770A1 (en) * | 2000-06-16 | 2001-12-20 | Transmit Technologietransfer | Treatment of solid tumors, especially brain tumors, using curcumin or derivative to inhibit peritumoral edema and tumor growth and kill the tumor cells |
JP2002030081A (en) * | 2000-07-13 | 2002-01-29 | Shiseido Co Ltd | Diaryl heptanoid derivative and matrix metalloprotease activity inhibitor |
KR20020073847A (en) * | 2001-03-16 | 2002-09-28 | 주식회사 바이오시너젠 | Composition for preventing or treating dementia comprising curcumin or extract of curcuma aromatica |
-
2002
- 2002-12-14 MX MXPA04005680A patent/MXPA04005680A/en active IP Right Grant
- 2002-12-14 JP JP2003552313A patent/JP4695839B2/en not_active Expired - Fee Related
- 2002-12-14 CA CA2473874A patent/CA2473874C/en not_active Expired - Fee Related
- 2002-12-14 BR BR0214962-1A patent/BR0214962A/en not_active IP Right Cessation
- 2002-12-14 KR KR1020047009174A patent/KR101001815B1/en not_active IP Right Cessation
- 2002-12-14 UA UA20040705723A patent/UA82057C2/en unknown
- 2002-12-14 EE EEP200400097A patent/EE05374B1/en not_active IP Right Cessation
- 2002-12-14 CN CNB028270770A patent/CN100528149C/en not_active Expired - Fee Related
- 2002-12-14 EA EA200400807A patent/EA007067B1/en not_active IP Right Cessation
- 2002-12-14 DE DE60233069T patent/DE60233069D1/en not_active Expired - Lifetime
- 2002-12-14 EP EP02781641A patent/EP1453528B1/en not_active Expired - Lifetime
- 2002-12-14 GE GE5642A patent/GEP20084442B/en unknown
- 2002-12-14 AU AU2002348802A patent/AU2002348802A1/en not_active Abandoned
- 2002-12-14 WO PCT/IB2002/005366 patent/WO2003051380A2/en active IP Right Grant
-
2004
- 2004-06-11 ZA ZA2004/04648A patent/ZA200404648B/en unknown
- 2004-07-02 LT LT2004060A patent/LT5284B/en not_active IP Right Cessation
- 2004-07-13 NO NO20043000A patent/NO332066B1/en not_active IP Right Cessation
- 2004-07-13 LV LVP-04-78A patent/LV13250B/en unknown
-
2005
- 2005-08-24 US US11/210,567 patent/US20060051438A1/en not_active Abandoned
-
2009
- 2009-05-18 US US12/467,383 patent/US20100093870A1/en not_active Abandoned
- 2009-09-07 AU AU2009212969A patent/AU2009212969B2/en not_active Ceased
Also Published As
Publication number | Publication date |
---|---|
JP2005516930A (en) | 2005-06-09 |
DE60233069D1 (en) | 2009-09-03 |
AU2009212969B2 (en) | 2011-06-02 |
LT2004060A (en) | 2005-06-27 |
KR20040073478A (en) | 2004-08-19 |
CN100528149C (en) | 2009-08-19 |
EA007067B1 (en) | 2006-06-30 |
US20060051438A1 (en) | 2006-03-09 |
WO2003051380A3 (en) | 2004-06-17 |
NO332066B1 (en) | 2012-06-18 |
US20100093870A1 (en) | 2010-04-15 |
EA200400807A1 (en) | 2004-12-30 |
LV13250B (en) | 2006-02-20 |
CA2473874A1 (en) | 2003-06-26 |
EE05374B1 (en) | 2011-02-15 |
WO2003051380A2 (en) | 2003-06-26 |
LT5284B (en) | 2005-11-25 |
BR0214962A (en) | 2004-12-14 |
MXPA04005680A (en) | 2004-10-15 |
KR101001815B1 (en) | 2010-12-15 |
CA2473874C (en) | 2011-11-22 |
EP1453528A2 (en) | 2004-09-08 |
AU2009212969A1 (en) | 2009-10-01 |
GEP20084442B (en) | 2008-08-10 |
EP1453528B1 (en) | 2009-07-22 |
EE200400097A (en) | 2004-10-15 |
ZA200404648B (en) | 2005-11-30 |
UA82057C2 (en) | 2008-03-11 |
AU2002348802A1 (en) | 2003-06-30 |
JP4695839B2 (en) | 2011-06-08 |
CN1615144A (en) | 2005-05-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20043000L (en) | A preparation for the treatment of neurocerebrovascular diseases | |
NO20033594D0 (en) | Phenethanolamine derivatives for the treatment of respiratory diseases | |
CY2014019I1 (en) | PHENETHANOLAMINE DERIVATIVES FOR THE TREATMENT OF RESPIRATORY DISEASES | |
NO20053077D0 (en) | Therapeutic formulations for the treatment of beta-amyloid-related diseases. | |
NO20041882L (en) | Methods for the treatment of ocular neovascular diseases. | |
NO20044402L (en) | Combination therapy of chemokine-mediated diseases | |
NO20031442D0 (en) | Morpholine-acetamide derivatives for the treatment of inflammatory diseases | |
NO20033143D0 (en) | Pharmaceutical preparation | |
NO20042680L (en) | Processes for the preparation of O-demethylvenflaxine | |
NO20031443D0 (en) | Compounds useful for the treatment of inflammatory diseases | |
NO20020133D0 (en) | Preparation for the treatment of external secretory disorders | |
AU2003219690A1 (en) | Fused bicyclic-n-bridged-heteroaromatic carboxamides for the treatment of disease | |
NO20026008D0 (en) | Procedure for the treatment of cardiovascular diseases | |
NO20031615L (en) | Pyrazole derivatives for the treatment of viral diseases | |
NO20033205D0 (en) | Therapeutic kroman compounds | |
NO20034864D0 (en) | Preparation for the treatment of drug-induced constipation with 15-keto-prostaglandins | |
DE60236743D1 (en) | FOR THE TREATMENT OF ANDROGEN-DEPENDENT DISEASES | |
NO20025805D0 (en) | Pharmaceutical preparation | |
FI20011889A0 (en) | Process for the preparation of xylitol | |
NO20044814L (en) | Process for the preparation of combretastanines | |
NO20035538D0 (en) | Process for the preparation of zaleplon | |
NO20035586L (en) | Process for the preparation of cyclohexanol derivatives | |
NO20042476L (en) | Use of desoxypeganine for the treatment of clinical depression | |
NO20012612L (en) | Isonipecotamides for the treatment of integrin-mediated diseases | |
NO20030717L (en) | Compounds for the treatment of addiction disorders |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM1K | Lapsed by not paying the annual fees |